FDA

Promising outcomes from the CAPItello-281 phase III study reveal that AstraZeneca’s Truqap (capivasertib) alongside abiraterone and androgen deprivation therapy (ADT) yielded a statistically significant and clinically notable enhancement in radiographic progression-free survival (rPFS) compared to abiraterone and ADT with a […]

GSK plc has disclosed that the United States Food and Drug Administration (FDA) has agreed to review the Biologics License Application (BLA) for Blenrep (belantamab mafodotin) when combined with bortezomib plus dexamethasone (BorDex [BVd]) and pomalidomide plus dexamethasone (PomDex [BPd]).

The Department of Pharmaceuticals (DoP) has dismissed a request by Neon Laboratories, based in Mumbai, to re-evaluate the ceiling price determination set by the National Pharmaceutical Pricing Authority (NPPA) for the steroid medication methylprednisolone 40 mg/ml injectable. Neon Laboratories reached

Industry experts have expressed their approval of the revised fee structure and the enforcement of mandatory Good Manufacturing Practices (GMP) compliance in the newly updated regulations for Ayurvedic, Siddha, Sowa-Rigpa, and Unani (ASSU) medicines. The new fee adaptation for ASSU

In accordance with the directive from the Calcutta High Court’s division bench in April, the West Bengal State Pharmacy Council (WB SPC) has recommenced the election process that was halted by the apex court’s single bench in February 2023. This

The Indian bio-pharmaceutical industry must allocate resources towards innovative research and development to remain competitive and leverage emerging global market opportunities. Emphasizing the strengthening of intellectual property (IP) assets, Dr. Jitendra Kumar, Managing Director of DBT-BIRAC, stated that prioritizing advanced

The Department of Biotechnology (DBT) is inviting researchers from leading research institutions, universities, and non-profit R&D organizations across the country to apply for its 2024-25 research associateship in biotechnology and life sciences. The program’s second call has been announced, with

### Clariant Enthusiastically Unveils Novel Health Care Products at CPHI India 2024 Clariant is thrilled to showcase its newest array of healthcare products at the upcoming CPHI India exhibition in Delhi NCR from November 26 to 28, 2024. This year’s

Smriti College of Pharmaceutical Education in Indore, Madhya Pradesh, marked the 63rd National Pharmacy Week (NPW) with exuberant events spanning November 17 to 23, 2024. The weeklong celebration encompassed a mix of educational, cultural, professional, and athletic activities designed to

Virpax Pharmaceuticals, Inc., a leader in non-addictive pain management, PTSD, CNS disorders, and antiviral barrier solutions, has unveiled findings from a Dose Range Finding (DRF) study using minipigs for Probudur, a liposomal bupivacaine formulation known for providing both immediate and